Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis
By
Lifei Yao
Qiong Li
Wei Peng
Aimeng Sun
Shaofen Li
Mengting Zou
Xianyun Xu
May 14, 2026
Clinical Scorecard: Extracellular Vesicles from Stem Cells as Modulators of Immunity: Addressing Pathological Interactions in Systemic Lupus Erythematosus and Multiple Sclerosis
At a Glance
Category Detail
Condition Systemic Lupus Erythematosus (SLE) and Multiple Sclerosis (MS) Key Mechanisms Dysregulated immune cell activation, autoantibody production, cytokine imbalance, compromised blood-brain barrier, and self-perpetuating neuroinflammatory cycles. Target Population Patients with SLE and MS, particularly young to middle-aged women. Care Setting Clinical settings focusing on autoimmune disease management.
Key Highlights
SLE and MS share overlapping clinical presentations and immunopathological features. Stem cell-derived extracellular vesicles (SC-EVs) can modulate immune responses in both diseases. MicroRNAs (miR-146a-5p and miR-21-5p) play a significant role in reprogramming immune responses. Extracellular vesicles facilitate intercellular communication and immune modulation. Preclinical studies indicate MSC-EVs can attenuate immune dysregulation and neuroinflammation. Guideline-Based Recommendations
Diagnosis
Consider overlapping symptoms of SLE and MS in patients with neurological manifestations. Management
Utilize broad-spectrum immunomodulators that address shared immune dysfunction. Monitoring & Follow-up
Monitor for neuropsychiatric manifestations in SLE patients that may mimic MS. Risks
Diagnostic confusion may compromise treatment efficacy and safety. Patient & Prescribing Data
Patients with chronic autoimmune diseases, specifically SLE and MS.
MSC-EVs show promise as cell-free therapeutic agents for mitigating autoimmune-mediated damage.
Clinical Best Practices
Integrate assessment of both SLE and MS symptoms in patient evaluations. Consider the use of SC-EVs in therapeutic strategies for immune modulation. Stay updated on emerging research regarding the role of microRNAs in treatment. Related Resources & Content
